Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Medscape Medical Affairs

Medscape's New Unit to Support Pharmaceutical Medical Affairs

Medscape Medical Affairs

- PMLiVE

How AI is finally helping rare diseases gain more than just attention

By Neil Thompson

- PMLiVE

WHO unveils new initiative to halt spread of invasive malaria vector in Africa

Anopheles stephensi thrives in urban settings, where 40% of the population in Africa live

- PMLiVE

NHS England launches lung cancer awareness drive in country’s cancer hotspots

Only 57% of those surveyed recognised a persistent cough as a symptom of lung cancer

- PMLiVE

InflaRx seeks FDA authorisation for vilobelimab for critically ill COVID-19 patients

A phase 3 study showed that the antibody reduced the all-cause mortality rate after 28 days

- PMLiVE

Medscape presents Digital Health in Practice: Impact & Insights at Reuters #Pharma2020

Medscape will be attending the Reuters Events Pharma 2022 conference from 11 – 13 October at Nice Acropolis Convention Center in Nice, France. The Medscape Professional Network will connect with...

Medscape Education

Overcoming Patient Recruitment Challenges in Rare Disease Trials

Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new...

Innovative Trials

- PMLiVE

A powerful care platform connects medical professionals and patients

Education platforms that disseminate the latest advances in cardiovascular medicine to cardiologists, physicians and healthcare professionals are helping deliver better outcomes for heart patients.

Medscape Education

- PMLiVE

Amylyx’s Relyvrio receives FDA approval for ALS treatment

Relyvrio was shown to significantly slow physical decline in people living with ALS

- PMLiVE

Cancer Research UK scientists announce ‘breakthrough’ in understanding of metastasis

The team found that cancer cells ‘exploit’ the body’s tissue repair process to spread cells

- PMLiVE

Sanofi and Regeneron’s Dupixent approved by FDA for prurigo nodularis

The two phase 3 trials showed a meaningful reduction in itching

Modern Medical Affairs: How to Leverage Tech and Data as an MSL

Dr. Luca Dezzani, VP of US Oncology Medical Affairs at Johnson & Johnson, explores innovation in Medical Affairs, new technologies for data dissemination and medical education, how to engage with...

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links